These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7024532)

  • 61. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
    Orscheln RC; Johnson DR; Olson SM; Presti RM; Martin JM; Kaplan EL; Storch GA
    J Infect Dis; 2005 Apr; 191(8):1272-9. PubMed ID: 15776373
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Pharyngitis produced by Arcanobacterium haemolyticum].
    Dorobăţ O; Erşcoiu S; Burtea M
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):135-40. PubMed ID: 9116401
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Contribution to the routine diagnosis of hemolytic streptococci (OBF-test according to Guthoof, CAMP-test, antibiogramm)].
    Biechteler W
    Zentralbl Bakteriol Orig; 1964 Jun; 193(1):48-56. PubMed ID: 5831675
    [No Abstract]   [Full Text] [Related]  

  • 64. Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae.
    Morrissey I; Maher K; Hawser S
    J Antimicrob Chemother; 2009 Feb; 63(2):413-4. PubMed ID: 19059943
    [No Abstract]   [Full Text] [Related]  

  • 65. Susceptibility to selected antibiotics of Streptococcus pneumoniae and Streptococcus pyogenes strains isolated from patients with respiratory tract infections.
    Mazur E; Ligieza J; Niedźwiadek J; Polak G; Kozioł-Montewka M; Hencner Z
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():407-10. PubMed ID: 11205800
    [No Abstract]   [Full Text] [Related]  

  • 66. [Resistance to macrolides in Streptococcus pyogenes].
    Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
    [No Abstract]   [Full Text] [Related]  

  • 67. COMPARISON OF THE FLUORESCENT ANTIBODY AND THE BACITRACIN DISK METHODS FOR THE IDENTIFICATION OF GROUP A STREPTOCOCCI.
    PETRAN EI
    Tech Bull Regist Med Technol; 1964 Jan; 34():8-10. PubMed ID: 14107498
    [No Abstract]   [Full Text] [Related]  

  • 68. An evaluation of the identification methods for beta-hemolytic streptococci group A.
    Vorachit M; Jayanetra P
    J Med Assoc Thai; 1975 Apr; 58(4):231-5. PubMed ID: 1094080
    [No Abstract]   [Full Text] [Related]  

  • 69. [Group differentiation of beta-hemolyzing streptococci with the aid of the OBF test by Guthof and the CAMP test].
    Pulverer G
    Zentralbl Bakteriol Orig; 1967; 204(2):301-4. PubMed ID: 4925334
    [No Abstract]   [Full Text] [Related]  

  • 70. Eradication of beta-haemolytic streptococci from the pharynx of healthy carriers with a single dose of ceftriaxone.
    Paradisi F; Bartoloni A; Aquilini D; Cacciuttolo R
    J Antimicrob Chemother; 1988 Apr; 21(4):515-6. PubMed ID: 3288606
    [No Abstract]   [Full Text] [Related]  

  • 71. A METHOD FOR RAPID DISTINCTION BETWEEN BETA-HAEMOLYTIC GROUP D STREPTOCOCCI AND BETA HAEMOLYTIC STREPTOCOCCI OF OTHER LANCEFIELD GROUPS.
    HOCKINGS KV
    J Med Lab Technol; 1965 Jan; 22():7-9. PubMed ID: 14253561
    [No Abstract]   [Full Text] [Related]  

  • 72. Agar-gel double diffusion for Lancefield grouping of beta haemolytic streptococci.
    Mondkar AD; Kelkar SS
    J Postgrad Med; 1982 Apr; 28(2):88-91. PubMed ID: 6813459
    [No Abstract]   [Full Text] [Related]  

  • 73. [Combined bacitracin and hemolysis inhibition test in practical group differentiation of hemolyzing streptococci].
    SCHNEWEIS KE; NIKFETRAT A
    Z Hyg Infektionskr; 1959; 145(5):450-60. PubMed ID: 13648554
    [No Abstract]   [Full Text] [Related]  

  • 74. Differentiation of group A from other beta hemolytic streptococci with bacitracin.
    LEVINSON ML; FRANK PF
    J Bacteriol; 1955 Mar; 69(3):284-7. PubMed ID: 14367273
    [No Abstract]   [Full Text] [Related]  

  • 75. Quantitative high-pressure liquid chromatographic analysis of bacitracin, a polypeptide antibiotic.
    Tsuji K; Robertson JH; Bach JA
    J Chromatogr; 1974 Nov; 99(0):597-608. PubMed ID: 4424759
    [No Abstract]   [Full Text] [Related]  

  • 76. A new method for preparing type-specific extracts from haemolytic streptococci of Group A, Type 2.
    ROSENDAL K
    Nature; 1950 Nov; 166(4230):912. PubMed ID: 14796626
    [No Abstract]   [Full Text] [Related]  

  • 77. Synthetic studies of bacitracin. II. Synthesis of a cyclic dodecapeptide, an analogue of bacitracin A.
    Ariyoshi Y; Shiba T; Kaneko T
    Bull Chem Soc Jpn; 1967 Nov; 40(11):2648-54. PubMed ID: 5586835
    [No Abstract]   [Full Text] [Related]  

  • 78. Septicaemia And Endocarditis Due to Streptococci of Lancefield Group.
    Mascart G; Dutaye J; Feremans W
    Acta Clin Belg; 1981 Jan; 36(4):209-12. PubMed ID: 27373461
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Some pharmacological characteristics of bacitracin.
    SCUDI JV; ANTOPOL W
    Proc Soc Exp Biol Med; 1947 Apr; 64(4):503-6. PubMed ID: 20239470
    [No Abstract]   [Full Text] [Related]  

  • 80. The bacitracin sensitivity test for identifying beta-haemolytic streptococci of Lancefield group A.
    Mondkar AD; Kelkar SS
    J Postgrad Med; 1981 Apr; 27(2):86-9. PubMed ID: 7024532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.